Clinical Trials in North Carolina

Showing 3241-3260 of 17,526 trials

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

NCT04325022

The purpose of this study is to assess the safety and effectiveness of the OR3O™ Dual Mobility System. The study will evaluate the outcome of the Total Hip Arthroplasty using the OR3O™ Dual Mobility System over a ten year period. Survivorship of THA will be assessed up to ten years.

Advanced Degeneration of the Hip JointRevision of the Hip Joint

Smith & Nephew, Inc.177 participantsStarted Jul 2020

Lexington, Kentucky, United States • Omaha, Nebraska, United States • New York, New York, United States +9 more locations

RECRUITINGPhase 341 miles

REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

NCT05625360

The purpose of this research study is to learn how two different supportive programs may help women feel better after surgery. This study will measure if one type of supportive program is more useful than the other for improving wellbeing after surgery.

Postoperative Pain, AcutePostoperative DepressionAnxiety+2 more

Wake Forest University Health Sciences160 participantsStarted Jun 2023

Charlotte, North Carolina, United States • Winston-Salem, North Carolina, United States

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss

Find Trials by Condition in North Carolina

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Phase 2b Study of GSK4532990 in Adults With NASH

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Young Adult Infusion Space Experience Satisfaction Survey

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS

Add-on Reparixin in Adult Patients With ARDS

A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study